Related Experiment Video

Updated: Apr 3, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

9.6K

Differential IKK/NF-κB Activity Is Mediated by TSC2 through mTORC1 in PTEN-Null Prostate Cancer and Tuberous

Yu Gao1, Ronald B Gartenhaus2, Rena G Lapidus2

  • 1Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland. Dalian Municipal Central Hospital Affiliated of Dalian Medical University, Dalian, Liaoning Province, P.R China.

Molecular Cancer Research : MCR
|September 17, 2015
PubMed
Abstract

Insights

The tumor suppressor TSC2 has a dual role in regulating NF-κB signaling. It inhibits this pathway in PTEN-deficient cancers but promotes it in TSC2-mutated tumors, offering new insights into cancer signaling.

Area of Science:

  • Molecular Biology
  • Cancer Signaling Pathways
  • Biochemistry

Background:

  • Akt signaling is crucial for cell proliferation, growth, and survival.
  • Akt promotes tumorigenesis by activating mTOR, often via TSC2 inhibition.
  • PTEN-null conditions involve Akt-mTOR activation and downstream signaling.

Purpose of the Study:

  • Investigate the mechanistic role of tumor suppressor TSC2 in regulating IKK/NF-κB activity.
  • Determine how TSC2 influences IKK/NF-κB signaling in PTEN-null prostate cancer.
  • Analyze TSC2's role in TSC2-mutated tumor cells.

Main Methods:

  • Investigated the mechanistic role of TSC2.
  • Analyzed IKK/NF-κB activity in PTEN-null and TSC2-mutated cancer cells.
  • Examined the relationship between TSC2, Akt, mTORC1, and IKK/NF-κB.

Main Results:

  • TSC2 inhibits IKK/NF-κB activity downstream of Akt and upstream of mTORC1 in PTEN-deficient environments.
  • TSC2 promotes IKK/NF-κB activity upstream of Akt and mTORC1 in TSC2-mutated tumor cells.
  • Demonstrated context-dependent regulation of IKK/NF-κB by TSC2 based on genetic background.

Conclusions:

  • TSC2 exhibits context-dependent negative or positive regulation of IKK/NF-κB signaling.
  • Provides fundamental insights into TSC2/mTOR regulation of NF-κB signaling in diverse tumor types.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.9K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

914

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.0K